These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9372243)

  • 41. Colonic expression of c-myb is initiated in utero and continues throughout adult life.
    Rosenthal MA; Thompson MA; Ellis S; Whitehead RH; Ramsay RG
    Cell Growth Differ; 1996 Jul; 7(7):961-7. PubMed ID: 8809414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of insulin-like growth factor-binding protein 5 in neuroblastoma cells is regulated at the transcriptional level by c-Myb and B-Myb via direct and indirect mechanisms.
    Tanno B; Negroni A; Vitali R; Pirozzoli MC; Cesi V; Mancini C; Calabretta B; Raschellà G
    J Biol Chem; 2002 Jun; 277(26):23172-80. PubMed ID: 11973331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ribosomal protein L4 positively regulates activity of a c-myb proto-oncogene product.
    Egoh A; Nosuke Kanesashi S; Kanei-Ishii C; Nomura T; Ishii S
    Genes Cells; 2010 Aug; 15(8):829-41. PubMed ID: 20604807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcription regulation by murine B-myb is distinct from that by c-myb.
    Watson RJ; Robinson C; Lam EW
    Nucleic Acids Res; 1993 Jan; 21(2):267-72. PubMed ID: 8382794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. c-myb intron I protein binding and association with transcriptional activity in leukemic cells.
    Dooley S; Seib T; Welter C; Blin N
    Leuk Res; 1996 May; 20(5):429-39. PubMed ID: 8683983
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular cloning reveals that the p160 Myb-binding protein is a novel, predominantly nucleolar protein which may play a role in transactivation by Myb.
    Tavner FJ; Simpson R; Tashiro S; Favier D; Jenkins NA; Gilbert DJ; Copeland NG; Macmillan EM; Lutwyche J; Keough RA; Ishii S; Gonda TJ
    Mol Cell Biol; 1998 Feb; 18(2):989-1002. PubMed ID: 9447996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A transcriptional arrest mechanism involved in controlling constitutive levels of mouse c-myb mRNA.
    Watson RJ
    Oncogene; 1988 Mar; 2(3):267-72. PubMed ID: 3281094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential regulation of c-Myb-induced transcription activation by a phosphorylation site in the negative regulatory domain.
    Miglarese MR; Richardson AF; Aziz N; Bender TP
    J Biol Chem; 1996 Sep; 271(37):22697-705. PubMed ID: 8798443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of A-myb induces basic fibroblast growth factor-dependent proliferation of chicken neuroretina cells.
    Turque N; Plaza S; Klempnauer KH; Saule S
    J Virol; 1997 Dec; 71(12):9778-81. PubMed ID: 9371644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Positive autoregulation of c-myb expression via Myb binding sites in the 5' flanking region of the human c-myb gene.
    Nicolaides NC; Gualdi R; Casadevall C; Manzella L; Calabretta B
    Mol Cell Biol; 1991 Dec; 11(12):6166-76. PubMed ID: 1944282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two regions in c-myb proto-oncogene product negatively regulating its DNA-binding activity.
    Tanaka Y; Nomura T; Ishii S
    FEBS Lett; 1997 Aug; 413(1):162-8. PubMed ID: 9287136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human A-myb gene encodes a transcriptional activator containing the negative regulatory domains.
    Takahashi T; Nakagoshi H; Sarai A; Nomura N; Yamamoto T; Ishii S
    FEBS Lett; 1995 Jan; 358(1):89-96. PubMed ID: 7821437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Only the DNA binding and transactivation domains of c-Myb are required to block terminal differentiation of murine erythroleukemia cells.
    Cuddihy AE; Brents LA; Aziz N; Bender TP; Kuehl WM
    Mol Cell Biol; 1993 Jun; 13(6):3505-13. PubMed ID: 8497265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sequence selectivity of c-Myb in vivo. Resolution of a DNA target specificity paradox.
    Andersson KB; Berge T; Matre V; Gabrielsen OS
    J Biol Chem; 1999 Jul; 274(31):21986-94. PubMed ID: 10419522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb.
    Dash AB; Orrico FC; Ness SA
    Genes Dev; 1996 Aug; 10(15):1858-69. PubMed ID: 8756344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding site analysis of c-Myb: screening of potential binding sites by using the mutation matrix derived from systematic binding affinity measurements.
    Deng QL; Ishii S; Sarai A
    Nucleic Acids Res; 1996 Feb; 24(4):766-74. PubMed ID: 8604322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myb protein specificity: evidence of a context-specific transcription factor code.
    Ness SA
    Blood Cells Mol Dis; 2003; 31(2):192-200. PubMed ID: 12972026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A-myb is expressed in bovine vascular smooth muscle cells during the late G1-to-S phase transition and cooperates with c-myc to mediate progression to S phase.
    Marhamati DJ; Bellas RE; Arsura M; Kypreos KE; Sonenshein GE
    Mol Cell Biol; 1997 May; 17(5):2448-57. PubMed ID: 9111313
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular events during myofibroblast activation: is there specificity?
    Trautwein C
    Hepatology; 1996 Sep; 24(3):742-4. PubMed ID: 8781355
    [No Abstract]   [Full Text] [Related]  

  • 60. Functional analysis of phosphorylation at serine 532 of human c-Myb by MAP kinase.
    Vorbrueggen G; Lovrić J; Moelling K
    Biol Chem; 1996 Nov; 377(11):721-30. PubMed ID: 8960373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.